ArticleBMC immunology2024

Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis.

Seyedeh Sadigheh Hamzavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.